DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Prochlorperazine Edisylate is a drug marketed by Morton Grove, Athenex Inc, Emcure Pharms Ltd, Hospira, Marsam Pharms Llc, Mylan Labs Ltd, Nexus Pharms, Smith And Nephew, Teva Parenteral, Watson Labs, West-ward Pharms Int, Wyeth Ayerst, and Alpharma Us Pharms. and is included in seventeen NDAs.
The generic ingredient in PROCHLORPERAZINE EDISYLATE is prochlorperazine edisylate. There are twenty-one drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the prochlorperazine edisylate profile page.
A generic version of PROCHLORPERAZINE EDISYLATE was approved as prochlorperazine edisylate by WEST-WARD PHARMS INT on August 29th, 1989.
Pharmacology for PROCHLORPERAZINE EDISYLATE
|Drug Class||Phenothiazine |